TRL Launches HepatoSite Blog | New Triangle Research Labs Blog Offers Thought Leadership into Hepatocyte Use in ADMETox Research

RESEARCH TRIANGLE PARK, N.C.-August 25, 2015 – TRL, the industry leading hepatocyte provider, announced the launch of HepatoSite, the company’s new blog. The biotech plans to reach scientists who regularly use hepatocytes and will find the information insightful, their audience typically includes:

  • Pharmaceutical Researchers
  • Contract Researchers
  • Biotechnology Researchers
  • Academic Researchers
  • Government researchers

The first HepatoSite blog entry details a study out of Johns Hopkins University’s Bloomberg School of Public Health involving the parasite that causes malaria. The study sourced cryopreserved human hepatocytes from TRL and included the company’s Executive Director, Matt Sherman as a contributing author.

Read the first blog entry here: www.trlcells.com/hepatositeblog

“TRL is establishing a blog to increase awareness of new developments in our field.  We hope to create a forum for scientists in our research area to discuss current issues, new technologies, and upcoming events,” explained Sherman.  “HepatoSite will present these topics in a non-biased format to encourage positive interactions between scientists from different institutions,” Sherman said, “with the goal to increase the visibility to industry-wide advancements that may help individuals achieve their research goals.”

The biotech plans to feature content that will highlight the use of hepatocytes in the scope of furthering their work with organizations that strive to improve the overall quality of human life. Hepatocytes are the primary functional cells in the human liver and perform most of the metabolic, endocrine, and secretory functions of the body.  The cells have become an essential component to many preclinical absorption, distribution, metabolism, elimination, and toxicity studies focused on drug development.

About TRL, LLC

At Triangle Research Labs, LLC (TRL), we produce high-quality hepatocytes for use in pre-clinical ADMETox applications.  We provide both human and animal, fresh and cryopreserved hepatocytes, and their relevant media. Additionally, our company distributes cryopreserved NoSpin HepaRG™ products for Biopredic International. A leader in quality and service, our expert staff has decades of experience in the hepatic sciences.

We are committed to providing high quality products that consistently exceed customer expectations. We build lasting relationships, understanding each customer’s specific needs, and work mutually towards the common goal of improving the quality of life.